Cited by 844Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersGenomic variations and chromosomal abnormalities

Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder

Open access
C Yuen, Ryan K, Merico, Daniele, Bookman, Matt, L Howe, Jennifer, Thiruvahindrapuram, Bhooma, Patel, Rohan V, Whitney, Joe, Deflaux, Nicole +75 more·2017·Nature Neuroscience

Abstract

We are performing whole-genome sequencing of families with autism spectrum disorder (ASD) to build a resource (MSSNG) for subcategorizing the phenotypes and underlying genetic factors involved. Here we report sequencing of 5,205 samples from families with ASD, accompanied by clinical information, creating a database accessible on a cloud platform and through a controlled-access internet portal. We found an average of 73.8 de novo single nucleotide variants and 12.6 de novo insertions and deletions or copy number variations per ASD subject. We identified 18 new candidate ASD-risk genes and found that participants bearing mutations in susceptibility genes had significantly lower adaptive ability (P = 6 × 10-4). In 294 of 2,620 (11.2%) of ASD cases, a molecular basis could be determined and 7.2% of these carried copy number variations and/or chromosomal abnormalities, emphasizing the importance of detecting all forms of genetic variation as diagnostic and therapeutic targets in ASD.

Integrity signals

Registry

Crossref · 10.1038/nn.4524

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The DLX5/6-N-Haplotype frequency in the MSSNG database of ASDs families showed a nonsignificant association (P = 0.16) with ASD.

    “we analyzed the DLX5/6-N-Haplotype frequency in the MSSNG database of ASDs families (Yuen et al. 2017), and we found a nonsignificant association (P = 0.16) with the disease.”
  • LoF variants in TAOK2 are identified in ASD probands, however it is not a top-ranking ASD risk factor by large genetic screening.

    “LoF variants in TAOK2 are identified in ASD probands [93, 94], however it is not a top-ranking ASD risk factor by large genetic screening [85].”
  • In humans, mutations in MAPK3 and TAOK2 but not in KCTD13 have been found in ASD cases.

    “In humans, mutations in MAPK3 [92] and TAOK2 [93, 94] but not in KCTD13 [85, 95] have been found in ASD cases.”
  • The genetic architecture in the self-reported SPARK cohort is similar to published, clinically confirmed ASD cohorts.

    “We also demonstrated that the genetic architecture in this self-reported cohort is similar to published, clinically confirmed ASD cohorts.3,4,7”
  • Over the past decade, genomic studies focused on de novo likely gene disrupting variants have identified about 100 high-confidence ASD risk genes or loci.

    “Over the past decade, genomic studies focused on de novo, likely gene disrupting (dnLGD) variants (stopgain, frameshift, and essential splice site) have identified ~100 high-confidence ASD risk genes or loci.3,4”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
C Yuen, R. K., Merico, D., Bookman, M., L Howe, J., Thiruvahindrapuram, B., Patel, R. V., Whitney, J., Deflaux, N., Bingham, J., Wang, Z., Pellecchia, G., Buchanan, J. A., Walker, S., Marshall, C. R., Uddin, M., Zarrei, M., Deneault, E., D'Abate, L., Chan, A. J. S., Koyanagi, S., Paton, T., Pereira, S. L., Hoang, N., Engchuan, W., Higginbotham, E. J., Ho, K., Lamoureux, S., Li, W., MacDonald, J. R., Nalpathamkalam, T., Sung, W. W. L., Tsoi, F. J., Wei, J., Xu, L., Tasse, A.-M., Kirby, E., Van Etten, W., Twigger, S., Roberts, W., Drmic, I., Jilderda, S., Modi, B. M., Kellam, B., Szego, M., Cytrynbaum, C., Weksberg, R., Zwaigenbaum, L., Woodbury-Smith, M., Brian, J., Senman, L., Iaboni, A., Doyle-Thomas, K., Thompson, A., Chrysler, C., Leef, J., Savion-Lemieux, T., Smith, I. M., Liu, X., Nicolson, R., Seifer, V., Fedele, A., Cook, E. H., Dager, S., Estes, A., Gallagher, L., Malow, B. A., Parr, J. R., Spence, S. J., Vorstman, J., Frey, B. J., Robinson, J. T., Strug, L. J., Fernandez, B. A., Elsabbagh, M., Carter, M. T., Hallmayer, J., Knoppers, B. M., Anagnostou, E., Szatmari, P., Ring, R. H., Glazer, D., Pletcher, M. T., & Scherer, S. W.
Affiliations
  • Hospital for Sick Children (CA)
  • Google (United States) (US)
  • University of Toronto (CA)
  • McGill University (CA)
  • Massachusetts Historical Society (US)
  • University of Alberta (CA)
  • McMaster University (CA)
  • Dalhousie University (CA)
  • Queen's University (CA)
  • Western University (CA)
  • Autism Speaks (US)
  • University of Illinois Chicago (US)
  • University of Washington (US)
  • Trinity College Dublin (IE)
  • Vanderbilt University (US)
  • Newcastle University (GB)
  • Boston Children's Hospital (US)
  • University Medical Center Utrecht (NL)
  • University of California San Diego (US)
  • Memorial University of Newfoundland (CA)
  • Children's Hospital of Eastern Ontario (CA)
  • Stanford Medicine (US)
  • Drexel University (US)
Corresponding author
Scherer, Stephen W
Venue
Nature Neuroscience
Published
2017-03-06
Volume
20
Issue
4
Pages
602-611
ISSN
  • 1097-6256 (ISSN-L)
  • 1546-1726
OpenAlex
W2591909999
Cited by
844
References
71
Citations by year
2026: 38 · 2025: 59 · 2024: 89 · 2023: 67 · 2022: 109 · 2021: 110 · 2020: 140 · 2019: 97 · 2018: 87 · 2017: 46 · 2016: 1
FWCI
58.10
Type
journal article
Language
en
Open access
Locations
  • Nature Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Scholarship@Western (Western University) (submittedVersion)
  • Utrecht University Repository (Utrecht University) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Canadian Institutes of Health Research (143295_1, 129338_1, 140849_1, 125818_1)
  • National Cancer Institute (U24CA210004)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083211)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
Keywords
autism spectrum disorder, candidate risk genes, de novo mutations, copy number variation, adaptive skills, genetic databases, chromosomal abnormalities
MeSH terms
Autism Spectrum Disorder, Chromosome Aberrations, Humans, Phenotype, Mutagenesis, Insertional, Sequence Deletion, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Databases, Genetic, Genome-Wide Association Study, DNA Copy Number Variations

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review